CHARLES RIVER LABORATORIES INTERNATIONAL, INC. Temporary Equity, Dividends, Adjustment
CHARLES RIVER LABORATORIES INTERNATIONAL, INC. (CRL) reported Temporary Equity, Dividends, Adjustment of $2.38 million for the 12-month period ending 2023-12-30, per its 10-K filed 2024-02-14.
Discontinued › Expense Statement › Operating Expenses
us-gaap:TemporaryEquityDividendsAdjustment · last filed 2024-02-14
- CHARLES RIVER LABORATORIES INTERNATIONAL, INC. temporary equity, dividends, adjustment for the quarter ending 2023-12-30 was $0.00.
- CHARLES RIVER LABORATORIES INTERNATIONAL, INC. temporary equity, dividends, adjustment for the quarter ending 2022-12-31 was $0.00.
- CHARLES RIVER LABORATORIES INTERNATIONAL, INC. temporary equity, dividends, adjustment for fiscal 2023 was $2.38M, a 32.54% decline from fiscal 2022.
- CHARLES RIVER LABORATORIES INTERNATIONAL, INC. temporary equity, dividends, adjustment for fiscal 2022 was $3.52M.
- CHARLES RIVER LABORATORIES INTERNATIONAL, INC. temporary equity, dividends, adjustment for fiscal 2021 was $0.00.
- CHARLES RIVER LABORATORIES INTERNATIONAL, INC. temporary equity, dividends, adjustment for fiscal 2020 was $0.00.
| Period end | Temporary Equity, Dividends, Adjustment 3 month | Temporary Equity, Dividends, Adjustment 9 month | Temporary Equity, Dividends, Adjustment 12 month |
|---|---|---|---|
| 2023-12-30 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-14 | $2.38M 10-K · filed 2024-02-14 | |
| 2023-09-30 | $2.38M 10-Q · filed 2023-11-08 | ||
| 2022-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-14 | $3.52M 10-K · filed 2024-02-14 | |
| 2022-09-24 | $3.52M 10-Q · filed 2023-11-08 | ||
| 2021-12-25 | $0.00 10-K · filed 2024-02-14 | ||
| 2020-12-26 | $0.00 10-K · filed 2023-02-22 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Medpace Holdings, Inc. (MEDP) | United States | $17.316B | 30.09 |
| INCYTE CORP (INCY) | United States | $24.855B | 13.14 |
| Absci Corp (ABSI) | United States | $1.775B | -14.92 |
| OmniAb, Inc. (OABI) | United States | $0.698B | -8.05 |
| NRC HEALTH (NRC) | United States | $0.450B | 42.50 |
| MAXCYTE, INC. (MXCT) | United States | $0.124B | -3.68 |
| bioAffinity Technologies, Inc. (BIAF) | United States | $0.063B | |
| OneMedNet Corp (ONMD) | $0.042B | ||
| iSpecimen Inc. (ISPC) | United States | $0.003B | |
| FOXO TECHNOLOGIES INC. (FOXO) | United States | $0.000B | -277.71 |